BLFE — Biolife Sciences Balance Sheet
0.000.00%
Last trade - 00:00
HealthcareHighly SpeculativeMicro Cap
- $0.00m
- $0.29m
2010 November 30th | 2011 November 30th | 2012 November 30th | 2020 November 30th | 2021 November 30th | |
---|---|---|---|---|---|
Period Length: | — | — | — | — | — |
Source: | ARS | ARS | 10-K | PROSPECTUS | PROSPECTUS |
Standards: | USG | USG | USG | USG | USG |
Status: | Final | Final | Final | Final | Final |
Cash and Equivalents | |||||
Cash and Short Term Investments | 0.005 | 0.003 | 0 | 0.035 | 0.017 |
Net Total Accounts Receivable | |||||
Net Total Receivables | 0 | 0 | — | — | — |
Prepaid Expenses | |||||
Total Current Assets | 0.005 | 0.003 | 0 | 0.072 | 0.077 |
Net Property, Plant And Equipment | 0 | 0 | 0 | 0.195 | 0.117 |
Net Goodwill | |||||
Net Intangible Assets | |||||
Total Assets | 0.239 | 0.003 | 0 | 0.267 | 0.194 |
Payable / Accrued | |||||
Accrued Expenses | |||||
Notes Payable / Short Term Debt | |||||
Current Portion of Long Term Debt / Capital Leases | |||||
Total Other Current Liabilities | |||||
Total Current Liabilities | 0 | 0.013 | 0.076 | 0.844 | 1.07 |
Long Term Debt | |||||
Total Long Term Debt | |||||
Total Debt | |||||
Total Other Liabilities | |||||
Total Liabilities | 0.008 | 0.053 | 0.083 | 0.957 | 1.07 |
Non Redeemable Preferred Stock | |||||
Common Stock | |||||
Additional Paid In Capital | |||||
Retained Earnings (Accumulated Deficit) | |||||
Other Equity | |||||
Total Equity | 0.231 | -0.05 | -0.083 | -0.69 | -0.88 |
Total Liabilities & Shareholders' Equity | 0.239 | 0.003 | 0 | 0.267 | 0.194 |
Total Common Shares Outstanding | |||||
Total Preferred Shares Outstanding |